Similar articles for PMID: 12427648

Year	Number of Results
1963	1
1965	1
1967	3
1971	1
1974	1
1975	1
1979	1
1981	1
1982	1
1983	1
1986	3
1987	1
1988	3
1989	2
1990	1
1991	3
1992	7
1993	5
1994	9
1995	3
1996	1
1997	6
1998	6
1999	9
2000	3
2001	8
2002	6
2003	6
2004	9
2005	7
2006	2
2007	5
2008	6
2009	6
2010	1
2011	6
2012	2
2013	8
2014	6
2015	3
2016	9
2017	8
2018	5
2019	6
2020	6
2021	7
2022	6
2023	3
2024	0

1

Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI).

Bittner V, Hardison R, Kelsey SF, Weiner BH, Jacobs AK, Sopko G; Bypass Angioplasty Revascularization Investigation. Bittner V, et al. Circulation. 2002 Nov 12;106(20):2537-42. doi: 10.1161/01.cir.0000038496.57570.06. Circulation. 2002. PMID: 12427648 Clinical Trial.

2

Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.

Nakamura T, Obata JE, Hirano M, Kitta Y, Fujioka D, Saito Y, Kawabata K, Watanabe K, Watanabe Y, Mishina H, Kugiyama K. Nakamura T, et al. Atherosclerosis. 2011 Sep;218(1):163-7. doi: 10.1016/j.atherosclerosis.2011.04.040. Epub 2011 May 6. Atherosclerosis. 2011. PMID: 21605862

3

The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: a one-year follow-up observational study.

Qiu W, Chen J, Huang X, Guo J. Qiu W, et al. Lipids Health Dis. 2020 Jul 6;19(1):163. doi: 10.1186/s12944-020-01340-5. Lipids Health Dis. 2020. PMID: 32631347 Free PMC article.

4

Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).

Tamis-Holland JE, Lu J, Korytkowski M, Magee M, Rogers WJ, Lopes N, Mighton L, Jacobs AK; BARI 2D Study Group. Tamis-Holland JE, et al. J Am Coll Cardiol. 2013 Apr 30;61(17):1767-76. doi: 10.1016/j.jacc.2013.01.062. Epub 2013 Feb 28. J Am Coll Cardiol. 2013. PMID: 23500245 Free article. Clinical Trial.

5

Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.

[No authors listed] [No authors listed] J Am Board Fam Pract. 1991 Sep-Oct;4(5):285-97. J Am Board Fam Pract. 1991. PMID: 1746296 Clinical Trial.

6

Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study.

Dai W, Zhang Z, Zhao S. Dai W, et al. Lipids Health Dis. 2018 Dec 3;17(1):273. doi: 10.1186/s12944-018-0923-1. Lipids Health Dis. 2018. PMID: 30509306 Free PMC article.

7

Assessment of coronary risk based on cumulative exposure to lipids in systemic lupus erythematosus.

Nikpour M, Gladman DD, Ibanez D, Harvey PJ, Urowitz MB. Nikpour M, et al. J Rheumatol. 2013 Dec;40(12):2006-14. doi: 10.3899/jrheum.121273. Epub 2013 Oct 15. J Rheumatol. 2013. PMID: 24128779

8

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J. Rubins HB, et al. N Engl J Med. 1999 Aug 5;341(6):410-8. doi: 10.1056/NEJM199908053410604. N Engl J Med. 1999. PMID: 10438259 Free article. Clinical Trial.

9

Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.

van den Berg MJ, van der Graaf Y, de Borst GJ, Kappelle LJ, Nathoe HM, Visseren FLJ; SMART Study Group. van den Berg MJ, et al. Am J Cardiol. 2016 Sep 15;118(6):804-810. doi: 10.1016/j.amjcard.2016.06.048. Epub 2016 Jun 28. Am J Cardiol. 2016. PMID: 27471056 Free article.

10

Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.

Arca M, Montali A, Valiante S, Campagna F, Pigna G, Paoletti V, Antonini R, Barillà F, Tanzilli G, Vestri A, Gaudio C. Arca M, et al. Am J Cardiol. 2007 Nov 15;100(10):1511-6. doi: 10.1016/j.amjcard.2007.06.049. Epub 2007 Oct 4. Am J Cardiol. 2007. PMID: 17996510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

191 results

Results by year